DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers. - Huang TT; Nair JR; Bowen C; Castro J; Nousome D; Nayak S; Silver SJ; Lee JM (Molecular cancer therapeutics, 2026)